1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Metastatic Platinum-Resistant Ovarian Carcinoma: new trials by email Literature Review of Metastatic Platinum-Resistant Ovarian Carcinoma trials Research Report on Metastatic Platinum-Resistant Ovarian Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers Biopsy Procedure, Biospecimen Collection, Cobimetinib - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 42 | 2023-09-14 | 2026-10-09 |
Carcinosarcoma (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1)
Adnexal Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Connective and Soft Tissue (1) · Sarcoma (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · cobimetinib (1) · pelcitoclax (1)
National Cancer Institute (NCI) (1)
United States (1)
Joyce F Liu (1)
UM1CA186709 (1)